• GlucoTrack entered an exchange agreement on July 22, 2026 with an investor tied to an existing promissory note.
• Carved out a new $900,000 promissory note from the existing note, reducing the remaining balance on the original instrument.
• Investor can exchange the partitioned note into common stock at a price set by recent Nasdaq closing prices.
• Conversions are capped by a 9.99% beneficial ownership limit, which could force issuance in tranches.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034815), on July 27, 2026, and is solely responsible for the information contained therein.